A critical breakthrough in cancer investigation is arising with the use of mini-antibodies to re-engage damaged p53. This crucial malignant protector protein is frequently inactivated in several forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research